Serum CA125 as a biomarker for dysmenorrhea in adenomyosis
article
OA: closed
CC0
⤵ 10 in-corpus citations
Abstract
OBJECTIVE: To explore the association between CA125 and dysmenorrhea in adenomyosis, and the factors affecting CA125 in adenomyosis. METHODS: Patients were grouped a the presence of dysmenorrhea. The receiver operating characteristic (ROC) curve was applied to assess the utility of CA125 for dysmenorrhea. Binary logistic regression was employed to identify the factors associating dysmenorrhea and CA125 level. RESULTS: Patients in the dysmenorrhea group had higher CA125 levels than those in the non-dysmenorrhea group. For those with dysmenorrhea, CA125 levels of diffuse subtype group were higher than those of the focal subtype group. The CA125 level of 35 U/mL was validated as the optimal cut-point for dysmenorrhea in ROC curves. Compared with patients whose CA125 was 35 U/mL or less, those with CA125 levels greater than 35 U/mL were more likely to have dysmenorrhea. Thereafter, the multiple regression analysis showed that adenomyotic lesion volume was positively correlated with CA125 level in the total cohort and subtype groups, while age was negatively correlated with CA125 level in the total cohort and diffuse subtype. CONCLUSIONS: The pathogenesis of adenomyosis is not clear. CA125 was associated with dysmenorrhea in adenomyosis, and, furthermore, CA125 level is positively correlated with the severity of the disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Adenomyosis: Mechanisms and Pathogenesis via openalex
- Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis via openalex
- Diagnosing adenomyosis: an integrated clinical and imaging approach via openalex
- Epidemiology of Adenomyosis via openalex
- Estrogen degrades Scribble in endometrial epithelial cells through E3 ubiquitin ligase HECW1 in the development of diffuse adenomyosis via openalex
- Expression of Inflammatory and Neurogenic Mediators in Adenomyosis: A Pathogenetic Role via openalex
- Gonadotrophin‐releasing hormone agonist combined with high‐intensity focused ultrasound ablation for adenomyosis: a clinical study via openalex
- Immunological changes associated with adenomyosis: a systematic review via openalex
- MRI for adenomyosis: a pictorial review via openalex
- Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis via openalex
- Relationship between Cyst Fluid Concentrations of Iron and Severity of Dysmenorrhea in Patients with Ovarian Endometrioma via openalex
- Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis via openalex
- Severe adenomyosis and CA125 via openalex
- Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- W6659946320 via openalex
- W6783937282 via openalex
- W6784688324 via openalex
- W1978393091 via openalex
- W7074078212 via openalex
- W1992451410 via openalex
- W1998812648 via openalex
- W2001866306 via openalex
- W2038396848 via openalex
- W2503974089 via openalex
- W2785096045 via openalex
- W2897457508 via openalex
- W2925925144 via openalex
- W2989384704 via openalex
- W3030082703 via openalex
- W3101128243 via openalex
- W3213017321 via openalex
- W6647489417 via openalex
- W6650896577 via openalex
Cited by (10)
- Regional homogeneity alterations reflect pain and emotional dysregulation in adenomyosis 2026
- Identification of diagnostic blood indicators associated with adenomyosis: a retrospective cohort study 2026
- The etiology differs regards to the locations of the lesion: a clinical experience of 1350 patients with adenomyosis confirmed by postoperative pathology 2025
- Deciphering the Pain-Related Gut Microbiome in Patients With Endometriosis 2025
- Comparison of safety and efficacy of hysteroscopic LNG-IUS fixation surgery and conventional LNG-IUS placement in the treatment of adenomyosis: A retrospective cohort study 2025
- Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location 2024
- Comprehensive analysis of circRNA-miRNA-mRNA regulatory network and novel potential biomarkers in eutopic endometrium of adenomyosis 2024
- Cytotoxic T Lymphocytes, Tc17 Cells, Th1 Cells, and ThGM Cells are Increased in the Blood and Ectopic Endometrium of Patients With Adenomyosis 2024
- Magnetic resonance imaging-based Classification criteria combined with Serum CA125 for dysmenorrhea before focused ultrasound ablation surgery in adenomyosis 2024
- Validation of an in vitro diagnostic test for endometriosis: impact of confounding medical conditions and lesion location 2024
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-01T00:33:45.861436+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK